Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20
2020 · Cell Death and Disease · 100 citations
https://doi.org/10.1038/s41419-019-2210-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Wei-Wei Ban is an academic researcher.
Click to start Chat